1-4 of 4
Vassilos I Avramis
Close
Sort by
Journal Articles

Pharmacokinetics-Based Modification of Intravenous Pegylated Asparaginase Dosing in the Context of a “Pediatric-inspired” Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Dan Douer, MD, Ibrahim Aldoss, MD, Matthew A Lunning, DO, Laleh Ramezani, BSc, Patrick Burke, MD, Lisa Mark, PA, Janice Vrona, PA-C, Jae H. Park, MD, Martin S Tallman, MD, Vinod Pullarkat, MD, Ann M Mohrbacher, MD, Vassilos I Avramis, PhD
Journal: Blood
Blood (2012) 120 (21): 1495.
https://doi.org/10.1182/blood.V120.21.1495.1495
Published: 2012
Journal Articles

Multiple Doses of Intravenous Pegylated Asparaginase with a “Pediatric-like” Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): Toxicity, Clinical Outcome and Low Rate of Anti Asparaginase Antibody Formation.

Dan Douer, Kristy Watkins, Lisa Mark, Janice Vrona, Ann Mohrbacher, MD, Allen S. Yang, Vassilos I Avramis
Journal: Blood
Blood (2009) 114 (22): 3082.
https://doi.org/10.1182/blood.V114.22.3082.3082
Published: 2009
Journal Articles

A Dose Intensified Pediatric-Like Regimen Using Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.

Dan Douer, MD, Kristy Watkins, RN, Lisa Mark, PA, Ann Mohrbacher, MD, Allen S. Yang, MD, PhD, Prakash N. Tiwari, MD, Vassilos I. Avramis, MD
Journal: Blood
Blood (2007) 110 (11): 2823.
https://doi.org/10.1182/blood.V110.11.2823.2823
Published: 2007
Journal Articles

The Pharmacokinetics, Safety and Lack of Antibody Production from Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.

Dan Douer, MD, Kristy Watkins, R.N., Niyati Nathwani, M.D., Alexandra M. Levine, M.D., Prakash N. Tiwari, M.D., Vassilos I. Avramis, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1873.
https://doi.org/10.1182/blood.V108.11.1873.1873
Published: 2006